carbapenems has been researched along with Candidiasis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boggian, K; Filipovic, M; Flury, D; Haller, S; Kleger, GR; Kohler, P; Nolte, O; Scanferla, G; Schlegel, M; Seiffert, SN; Seneghini, M; Thoma, R; Vuichard Gysin, D | 1 |
| Blythe, D; French, I; Harris, AD; Heller, A; Johnson, JK; Klein, L; O'Hara, LM; Perlmutter, R; Pineles, L; Rubin, J; Smith, LL; Thoguru, J; Vaeth, E | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
| Aguilar, L; Gilsanz, F; Gimenez, MJ; Maseda, E | 1 |
| Ben-Ami, R; Bishara, J; Block, C; Chazan, B; Chowers, M; Dan, M; Giladi, M; Kassis, I; Keller, N; Kontoyiannis, DP; Krieger, M; Olshtain-Pops, K; Oren, I; Potasman, I; Shalit, I; Weber, G; Weinberger, M; Wiener-Well, Y; Zimhony, O | 1 |
| Dimopoulou, D; Galanakis, E; Kofteridis, DP; Maraki, S; Ntaoukakis, M; Samonis, G; Sarchianaki, E; Spathopoulou, T | 1 |
| Benjamin, DK; Cotten, CM; Goldberg, RN; McDonald, S; Poole, K; Stoll, B | 1 |
| Hu, Y; Li, LQ; Yu, JL | 1 |
2 review(s) available for carbapenems and Candidiasis
| Article | Year |
|---|---|
The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literatu
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Candida auris; Candidiasis; Carbapenems; COVID-19; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Infection Control; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Switzerland | 2022 |
Basis for selecting optimum antibiotic regimens for secondary peritonitis.
Topics: Abdominal Cavity; Anti-Bacterial Agents; Candida; Candidiasis; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Peritonitis; Practice Guidelines as Topic; Risk Factors; Tigecycline | 2016 |
6 other study(ies) available for carbapenems and Candidiasis
| Article | Year |
|---|---|
Prevalence of Acinetobacter baumannii and Candida auris in Patients Receiving Mechanical Ventilation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Candida auris; Candidiasis; Carbapenems; Cross-Sectional Studies; Drug Resistance, Microbial; Health Facilities; Humans; Maryland; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Respiration, Artificial | 2023 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida glabrata; Candidemia; Candidiasis; Carbapenems; Clindamycin; Coinfection; Colistin; Drug Resistance, Fungal; Female; Fluconazole; Humans; Israel; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Carbapenems; Disease Models, Animal; Drug Therapy, Combination; Gastrointestinal Tract; Humans; Male; Mice | 2013 |
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.
Topics: Blood; Candidiasis; Carbapenems; Catheterization, Central Venous; Central Nervous System Fungal Infections; Cephalosporins; Cerebrospinal Fluid; Comorbidity; Cross Infection; Enterocolitis, Necrotizing; Fungemia; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Prospective Studies; Registries; Risk Factors; Superinfection | 2006 |
[Clinical value and multiple risk factors analysis of sputum culture for fungus in neonates].
Topics: Anti-Bacterial Agents; Candida; Candidiasis; Carbapenems; Child; Clinical Laboratory Techniques; Fungi; Humans; Incidence; Infant; Infant, Newborn; Mycoses; Pneumonia; Risk Factors; Sputum | 2007 |